Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract Infections
Part of paid clinical trials in Kansas City, Kansas.
- Sponsor
- University of Texas Southwestern Medical Center
- Study ID
- NCT06907199
- Phase
- PHASE1
- Status
- Recruiting
Conditions
- Cystitis Recurrent
- Recurrent UTIs
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Electrofulguration (EF) — PROCEDURENitrofurantoin (NF) daily antibiotic prophylaxis for 6 months plus Electrofulguration.
- Nitrofurantoin (NF) — DRUGNitrofurantoin (NF) daily antibiotic prophylaxis given daily for 6 months.
Study Details
The goal of this clinical trial is to learn if the drug Nitrofurantoin (NF) taken as a daily antibiotic, works to treat cystitis compared to electrofulguration (EF) and Nitrofurantoin (NF) daily antibiotic.
Key Dates
- Start date
- Apr 6, 2026
- Status verified
- Apr 2026
- Primary completion
- Jul 1, 2028
- Completion
- Jan 30, 2029
Study Design
- Enrollment
- 104 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Nitrofurantoin (NF) daily antibiotic prophylaxisNitrofurantoin (NF) daily antibiotic prophylaxis given daily for 6 months.
- Experimental: Nitrofurantoin (NF) daily antibiotic prophylaxis plus electrofulguration (EF)
Primary Outcome Measure
Treatment of cystitis with NF vs EF+NF [ Time Frame: Baseline to 30 months after enrollment to completion of study ]
Central Contacts
- Meghan Leak214-645-8787
- Philippe Zimmern, M.D.
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Kansas | Kansas City | Kansas | 66160 | Colby Souders, MD (PRINCIPAL_INVESTIGATOR) |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | Philippe Zimmern, MS (PRINCIPAL_INVESTIGATOR) Colby Souders, MD (SUB_INVESTIGATOR) |
Find similar trials in Kansas City, KS
Related Studies
- A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract InfectionsRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas